CM Fadnavis launches Mahacare for world-class cancer care in Maharashtra
Synopsis
Chief Minister Devendra Fadnavis chaired the first board meeting of Maharashtra Cancer Care, Research and Education Foundation (Mahacare) in Mumbai on 16 July 2026, approving a ₹100 crore corpus from Mahatma Phule Jan Arogya Yojana, a Tata Memorial Hospital MoU, and a nine-city district cancer centre network to deliver world-class oncology care across every Maharashtra district.
Key Takeaways
CM Devendra Fadnavis chaired the inaugural board meeting of Mahacare at Sahyadri Guest House, Mumbai on 16 July 2026 . ₹100 crore from the Mahatma Phule Jan Arogya Yojana approved in principle as Mahacare's corpus fund.
An MoU signed with Tata Memorial Cancer Hospital for technical collaboration in research and treatment.
The Nagpur High Energy Medical Cyclotron Project subsidiary approved under Mahacare to produce radioisotopes in central Maharashtra.
Nine comprehensive cancer treatment centres planned across Mumbai, Pune, Chhatrapati Sambhajinagar, Nagpur, Nanded, Kolhapur, Chandrapur, Nashik, and Amravati .
Nine diagnosis and day-care centres to be established in cities including Ratnagiri, Satara, Baramati, Jalgaon, Yavatmal, Thane, and Shirdi .
The Chief Minister's Office of Maharashtra announced on Thursday, 16 July 2026 that Chief Minister Devendra Fadnavis chaired the inaugural board meeting of the Maharashtra Cancer Care, Research and Education Foundation (Mahacare) at Sahyadri Guest House, Mumbai, directing the foundation to build international-standard cancer treatment and research facilities across every district of the state.
Context
The CMO's post, written in Marathi, announced: 'राज्यात उभारणार जागतिक दर्जाची कर्करोग उपचार व्यवस्था' — 'A world-class cancer treatment system will be established in the state.' At the meeting, CM Fadnavis directed Mahacare to create international-standard treatment and research facilities for cancer patients in Maharashtra through a decentralised service model. He specifically instructed that only high-calibre human resources be recruited to build the organisation's workforce.
The board also approved a Memorandum of Understanding (MoU) with Tata Memorial Cancer Hospital for technical collaboration — a significant institutional partnership linking the state's new cancer body with one of India's most established oncology centres.
Policy Backdrop
Mahacare is designed to function through L2 and L3 state-run cancer hospitals equipped with modern technology, ensuring that every person in every district of Maharashtra receives equal, world-class cancer care — from diagnosis to treatment. The board gave in-principle approval to allocate ₹100 crore from the Mahatma Phule Jan Arogya Yojana as Mahacare's corpus fund. The Mahatma Phule Jan Arogya Yojana, launched in 2012, has been Maharashtra's primary vehicle for extending tertiary health coverage to low-income families.
The meeting also approved the establishment of a subsidiary — the Nagpur High Energy Medical Cyclotron Project — under Mahacare in Nagpur, which will build advanced radioisotope production capacity in central Maharashtra. Additional approvals covered raising and accepting CSR funds, allotting office space in the G.T. Hospital building for Mahacare's headquarters, and appointing the company's auditors, company secretary, and consultants.
Scope and Stakeholder Impact
The Mahacare network as announced covers three tiers. At the apex, Tata Memorial Hospital will serve as the premier research and treatment centre. Below it, nine district-level comprehensive cancer treatment centres are planned in Mumbai, Pune, Chhatrapati Sambhajinagar, Nagpur, Nanded, Kolhapur, Chandrapur, Nashik, and Amravati. A third tier of nine diagnosis and day-care centres will come up in Mumbai (Cama Albless), Ratnagiri, Satara, Baramati, Jalgaon, Yavatmal, Ambajogai (Beed), Thane, and Shirdi.
State-wide implementation will proceed through the Maha Arogya project. The framework directly benefits cancer patients who currently travel to Mumbai or Pune for advanced care, and is expected to reduce the overall cancer burden in the state. Minister Prakash Abitkar, Minister of State Madhuri Misal, Mahacare CEO Dr. Ajay Chandanwale, and senior officials were present at the meeting.
What's Next
The immediate priorities are operationalising the Tata Memorial MoU, deploying the ₹100 crore corpus, and advancing the Nagpur High Energy Medical Cyclotron Project. The phased rollout of all nine district cancer centres and nine diagnostic units will be a key indicator of whether Mahacare can deliver on its mandate of equitable, world-class oncology services beyond Maharashtra's metros. Utilisation data from the corpus fund and early outcomes from the Tata Memorial technical partnership will be closely watched by health-policy observers and patient groups alike.
Point of View
State-managed system — a model other large Indian states have been piloting under national frameworks like NPCDCS and Ayushman Bharat. Anchoring the foundation's credibility with a Tata Memorial MoU is a politically astute move: it lends institutional legitimacy while the state builds its own capacity. The ₹100 crore corpus drawn from Mahatma Phule Jan Arogya Yojana signals intent to integrate insurance-funded access with infrastructure, though the real test will be whether district centres become functional within a defined timeframe rather than remaining on paper. For CM Fadnavis, Mahacare also serves as a visible welfare deliverable ahead of any political cycle, making health equity a tangible governance narrative.
NationPress
16 Jul 2026
Frequently Asked Questions
What is Mahacare Maharashtra?
Mahacare — short for Maharashtra Cancer Care, Research and Education Foundation — is a state-promoted company set up by the Maharashtra government to build decentralised, international-standard cancer treatment, research, and education facilities across all districts of the state.
How much money has been allocated to Mahacare?
The Maharashtra government has given in-principle approval to allocate ₹100 crore from the Mahatma Phule Jan Arogya Yojana as the corpus fund for Mahacare.
Which cities will get cancer treatment centres under Mahacare?
Nine comprehensive cancer centres are planned in Mumbai, Pune, Chhatrapati Sambhajinagar, Nagpur, Nanded, Kolhapur, Chandrapur, Nashik, and Amravati . An additional nine diagnosis and day-care centres will come up in cities including Ratnagiri, Satara, Baramati, Jalgaon, Yavatmal, Thane, Shirdi, and Mumbai's Cama Albless facility.
What is the Nagpur High Energy Medical Cyclotron Project?
It is a subsidiary company approved under Mahacare to be established in Nagpur , aimed at creating advanced radioisotope production capacity in central Maharashtra to support cancer diagnosis and treatment.
What is the role of Tata Memorial Hospital in Mahacare?
Tata Memorial Cancer Hospital has signed an MoU with Mahacare for technical collaboration. Within the Mahacare network, Tata Memorial is designated as the apex centre for research and cancer treatment, providing expertise and institutional support to the state's new cancer infrastructure.
